This SAMHSA page includes information on 2023 training requirements that eliminated the DATA waiver that was previously needed to prescribe buprenorphine and expanded the number of DEA-registered practitioners able to treat people with opioid use disorder.
Source
Substance Abuse and Mental Health Services Administration (SAMHSA)
Year
Format
Terms of Use
Topic
Resource Type
Special Collection